News Search

Columbia is leading the movement to add neurocognitive screening to annual well woman OB/GYN checkups.

Neil Shneider, MD, PhD, discusses how patients have fared in the phase three trial of tofersen and how the drug will impact ALS treatment in the future.

Most abnormal cells found with a Pap test are not cancerous, but following up with your gynecologist is important.

Many guidelines suggest women should start getting bone density tests to detect osteoporosis at age 65, but earlier testing may help prevent more fractures.